Intercell (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Intercell" in English language version.

refsWebsite

Global rank English rank

low place

low place

2web.archive.org

1^st place

1^st place

1fiercebiotech.com

low place

8,828^th place

low place

low place

99^th place

77^th place

49^th place

47^th place

5^th place

5^th place

low place

low place

bloomberg.com

"The Dark Horse of the Vaccine Race May Be This French Biotech". Bloomberg.com. 2021-04-29. Retrieved 2023-01-09.

fdanews.com

"Intercell Hepatitis C Vaccine Meets Primary Endpoints". FDA News. 2007-08-22. Retrieved 2008-08-15.

fiercebiotech.com

Carroll, John (17 December 2012). "Troubled Intercell throws in the towel, signs off on merger deal with Vivalis". Fierce Biotech. Retrieved 27 January 2018.

imp.ac.at

"Research Institute of Molecular Pathology (IMP) - About the IMP > History". Research Institute of Molecular Pathology. Retrieved 2009-07-25. ^{[dead link]}

intercell.com

"Annual Report 2010" (PDF). Intercell. Archived from the original (PDF) on 26 June 2011. Retrieved 3 May 2011.
"Intercell's Japanese Encephalitis Vaccine FDA approval". Medical News Today. 2009-03-31. Retrieved 2009-03-31. ^{[dead link]}
"Intercell's Japanese Encephalitis Vaccine EMEA approval for Europe". Intercell. 2009-04-02. Retrieved 2009-04-02. ^{[dead link]}
"Intercell's Japanese Encephalitis Vaccine Australian TGA approval". Intercell. 2009-01-23. Retrieved 2009-01-23. ^{[dead link]}

reuters.com

Fox, Maggie; Grenon, Andre (2008-05-12). "Austrian vaccine maker Intercell buys Iomai". Reuters. Archived from the original on 2011-06-20. Retrieved 2008-08-15.

web.archive.org

"Annual Report 2010" (PDF). Intercell. Archived from the original (PDF) on 26 June 2011. Retrieved 3 May 2011.
Fox, Maggie; Grenon, Andre (2008-05-12). "Austrian vaccine maker Intercell buys Iomai". Reuters. Archived from the original on 2011-06-20. Retrieved 2008-08-15.

worldcat.org

search.worldcat.org

Staff (1 June 2008), "Intercell to Acquire Iomai for $189M", Genetic Engineering & Biotechnology News, News: Inside Industry, vol. 28, no. 11, Mary Ann Liebert, Inc., p. 14, ISSN 1935-472X